A new international research study will focus on treatment strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with known or suspected COVID-19.

ZOLL Medical Corporation has gained FDA approval for its new SuperSaturated Oxygen (SSO2) therapy solution for treating heart muscle damage in “widowmaker” heart attacks patients.

Homeless patients receive fewer treatments and experience higher readmission rates when hospitalized for a heart attack than other patients, according to new findings published in Mayo Clinic Proceedings.

The presence of mental stress is a key predictor of when MI patients may have a repeat MI or die from heart disease, according to new research highlighted by the American College of Cardiology.

The Mayo Clinic researchers were "surprised" at how far the intervention restored the diseased hearts back to normal.

Heart patients who follow all guideline-recommended medical advice after an MI are far more likely than their peers to survive for years after a heart attack, researchers reported in the Journal of the American Heart Association this month.

Brigham and Women’s Hospital physicians have discovered that irregular sleep patterns can significantly hike a person’s risk for heart disease, even if they’re otherwise healthy.

A secondary analysis of the AUGUSTUS trial confirms earlier findings that treating heart patients with the anticoagulant apixaban results in less major bleeding, hospitalization and death than warfarin, a standard-of-care blood thinner.